OxyCotin Maker Purdue Pharma Petitions for Chapter 11 Bankruptcy



DOCUMENTS
  • Petition


NEW YORK — Purdue Pharma L.P., maker of the addictive painkiller OxyCotin, has filed a voluntary petition for Chapter 11 bankruptcy in New York federal court following its agreement to settle thousands of lawsuits accusing it of perpetuating the opioid epidemic.

The petition, filed on Sept. 15 in the U.S. Bankruptcy Court for the Southern District of New York, also comes on the heels of allegations that the company’s owners secretly wired nearly $1 billion to private accounts.

According to the petition, Purdue’s creditors are comprised largely of state and federal opioid litigants, including state departments of health and human …






UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Surgical Stapler Litigation

January 14, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin's Webinar Series: Midwest Asbestos Litigation

December 02, 2020 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS